Feasiblity study of MR-guided stereotactic body radiotherapy for non-metastatic unresectable pancreatic cancer
Phase 1
- Conditions
- Pancreatic cancer
- Registration Number
- JPRN-UMIN000035135
- Lead Sponsor
- ational Cancer Center Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 5
Inclusion Criteria
Not provided
Exclusion Criteria
Active multiple primary cancer Infectious diseases requiring systemic treatment Fever of 38 degrees Celcius or higher Women with pregnancy, with possible pregnancy, during lactation, or within 28 days after giving birth, and men who expect the partner's pregnancy Psychiatric illness or psychological symptoms Other severe comorbidity Problems in taking MRI Unstable angina, or history of myocardial infarction within 6 months Contraindication to both contrast agents of iodinated and gadolinium-based, due to drug allergy
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The feasibility of MR-guided stereotactic body radiotherapy for unresectable pancreatic cancer without distant metastasis
- Secondary Outcome Measures
Name Time Method